Latest News
DTx Pharma Announces Presentations at Several Upcoming Virtual Medical Meetings
DTx Pharma, Inc. (DTx), a privately-held biotechnology company creating novel RNA-based therapeutics to treat the genetic drivers of disease, announced today that the company will be presenting at several upcoming virtual medical meetings. Charles Allerson, Ph.D., DTx's VP of Chemistry, [...]
DTx Pharma Announces Appointment of Bryan Laffitte, Ph.D. as Vice President, Biology
DTx Pharma, Inc. (DTx), a privately-held biotechnology company creating novel RNA-based therapeutics to treat the genetic drivers of disease, announced today the appointment of Bryan Laffitte, Ph.D., as Vice President, Biology. In his newly created role, Dr. Laffitte will [...]
DTx Pharma Expands Footprint in San Diego with New Office and Lab Space
SAN DIEGO, May 20, 2020 /PRNewswire/ -- DTx Pharma, Inc. (DTx), a privately-held biotechnology company creating novel RNA-based therapeutics to treat the genetic drivers of disease, announced today the expansion of its footprint into a new 14,000 square foot lab [...]
DTx Pharma Receives Prestigious Funding Award to Support Research in Neurodegenerative Diseases of the CNS
-DTx was one of 8 grantees selected out of more than 100 academic and company applicants worldwide- SAN DIEGO, May 13, 2020 /PRNewswire/ -- DTx Pharma, Inc. (DTx), a privately-held biotechnology company creating novel RNA-based therapeutics to treat the genetic [...]
DTx Pharma Completes $10.6M Series A Financing
DTx Pharma announced today the final closing of a Series A financing totaling $10.6 million dollars. The round was led by San Diego-based FBV Fund 1 and included significant investment from Eli Lilly and Company (NYSE: LLY), Viva Biotech [...]
Partnership with DTx Pharma to optimize antisense oligonucleotides as a gene therapy for CMT1A
The CMT Research Foundation (CMTRF), a nonprofit focused solely on delivering treatments and cures for Charcot-Marie-Tooth, today announced it has partnered with DTx Pharma, an RNA medicines company breaking open new therapeutic areas for oligonucleotide (short DNA or RNA molecules) drugs by overcoming [...]